APA Zitierstil

Ma, C., Chang, T., Tsai, H., Su, W., Huang, C., Yeh, Y., . . . Wang, J. (2019). Regorafenib plus FOLFIRI with irinotecan dose escalated according to uridine diphosphate glucuronosyltransferase 1A1genotyping in previous treated metastatic colorectal cancer patients: Study protocol for a randomized controlled trial. Trials.

Chicago Zitierstil

Ma, Cheng-Jen, Tsung-Kun Chang, Hsiang-Lin Tsai, Wei-Chih Su, Ching-Wen Huang, Yung-Sung Yeh, Yu-Tang Chang, und Jaw-Yuan Wang. "Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated According to Uridine Diphosphate Glucuronosyltransferase 1A1genotyping in Previous Treated Metastatic Colorectal Cancer Patients: Study Protocol for a Randomized Controlled Trial." Trials 2019.

MLA Zitierstil

Ma, Cheng-Jen, et al. "Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated According to Uridine Diphosphate Glucuronosyltransferase 1A1genotyping in Previous Treated Metastatic Colorectal Cancer Patients: Study Protocol for a Randomized Controlled Trial." Trials 2019.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.